Spacetech News and Headlines
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests
NewsDealsSocialBlogsVideosPodcasts
SpacetechNewsSpaceX Crew-12 Will Study How Microgravity Affects the Human Body
SpaceX Crew-12 Will Study How Microgravity Affects the Human Body
SpaceTechBioTech

SpaceX Crew-12 Will Study How Microgravity Affects the Human Body

•February 7, 2026
0
Universe Today
Universe Today•Feb 7, 2026

Companies Mentioned

SpaceX

SpaceX

Why It Matters

Understanding clot formation and cognitive performance in altered gravity is essential for protecting astronaut health on long‑duration missions, directly influencing the feasibility of sustained lunar and Martian exploration.

Key Takeaways

  • •Venous Flow study examines clot risk in microgravity.
  • •Headward fluid shift alters circulatory patterns during flight.
  • •Manual Piloting study assesses lunar‑landing disorientation.
  • •Findings will guide Artemis crew training and safety protocols.
  • •Research includes ultrasound, MRI, and blood‑pressure monitoring.

Pulse Analysis

Understanding how the human body responds to microgravity has been a cornerstone of space‑flight research since the early days of the International Space Station. Decades of data have documented bone loss, muscle atrophy, vision changes, and cardiovascular adaptations, yet each new mission uncovers subtle physiological shifts that can jeopardize crew health on longer voyages. As NASA’s Artemis program moves toward sustained lunar presence and the eventual Mars transit, the need for precise, mission‑specific biomedical data becomes critical for designing countermeasures and ensuring astronaut safety.

The Venous Flow investigation on Crew‑12 targets one of the less‑publicized but potentially lethal risks: blood‑clot formation in a weightless environment. In microgravity, fluids migrate toward the head, increasing venous pressure and altering shear stress on vessel walls. Astronauts will perform self‑administered jugular‑vein ultrasounds, coupled with blood draws and pressure checks, providing real‑time insight into clot‑forming mechanisms. These data will inform pre‑flight screening, in‑flight anticoagulant protocols, and post‑flight rehabilitation, directly reducing the likelihood of stroke, pulmonary embolism, or deep‑vein thrombosis on deep‑space missions.

Equally vital is the Manual Piloting study, which simulates lunar‑landing scenarios to evaluate cognitive and motor performance during gravity transitions. By exposing crew members to rapid shifts from microgravity to 0.165 g, researchers can quantify disorientation and its impact on decision‑making, a factor that could compromise autonomous landings on the Moon’s South‑Pole‑Aitken Basin or future Martian descent. The outcomes will shape training curricula, cockpit interface design, and contingency procedures for Artemis crews, ensuring that astronauts retain manual control capabilities when automated systems fail.

SpaceX Crew-12 will Study How Microgravity Affects the Human Body

Read Original Article
0

Comments

Want to join the conversation?

Loading comments...